Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amicus
Amicus
FDA Has Ways to Go to Keep Pace with 2020/21 Approvals
BioSpace
Wed, 07/6/22 - 11:05 am
FDA
drug approvals
Amicus
Bluebird Bio
Bristol Myers Squibb
Eli Lilly
Marinus Pharma
Amylyx
Novartis
In anticipation of PhIII trial results, Amicus pares down old debt with $400 million loan
Endpoints
Fri, 07/17/20 - 11:03 am
Amicus
Pompe disease
clinical trials
Pompe Disease Patients on Amicus Drug Continue to Improve in Study
Xconomy
Wed, 02/7/18 - 10:11 pm
Pompe disease
Amicus
ABT200
Amicus CEO directly lobbied FDA’s Gottlieb to reverse FDA’s rejection of migalastat, claiming a delay of up to 7 years
Endpoints
Fri, 12/15/17 - 09:33 am
Amicus
Pharma CEOs
FDA
Scott Gottlieb
migalastat
Fabry disease
Amicus’s Scioderm Deal Flops as Skin Drug Fails in Phase 3
Xconomy
Wed, 09/13/17 - 09:39 am
Amicus
Scioderm
clinical trials
epidermolysis bullosa
Amicus CEO John Crowley, Not His Daughter Megan, Might Compel Trump to Make Big Changes at FDA
TheStreet.com
Wed, 03/1/17 - 10:19 am
Amicus
Pharma CEOs
John Crowley
Rare Diseases
Donald Trump
FDA
On second thought, Amicus won't be filing its lead drug this year
Fierce Biotech
Fri, 10/2/15 - 10:45 am
Amicus
FDA
migalastat
Fabry's disease
Why Genzyme isn't worried about a threat by Amicus to its next Fabry drug
Bizjournals.com
Mon, 07/20/15 - 11:32 pm
Genzyme
Amicus
Fabry's disease
Cerezyme
Fabrazyme
Sanofi
Amicus' rare disease drug lines up for a quick EU approval
Fierce Biotech
Tue, 05/26/15 - 09:52 am
Amicus
Europe
migalastat
Fabry's disease
Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win
TheStreet.com
Wed, 08/20/14 - 08:06 am
Fabry's disease
Amicus
Migalastat HCl
GSK
Busy Biogen Idec fuels Amicus in Parkinson's drug chase
Fierce Biotech
Tue, 09/10/13 - 11:28 am
Biogen Idec
Amicus
Parkinson's Disease
Amicus Delays U.S. Approval Filing for Fabry Disease Drug
TheStreet.com
Mon, 06/17/13 - 09:31 am
Fabry's disease
Amicus
GSK
Amigal
A Legit Reason To Give Amicus' Fabry Drug Another Chance
TheStreet.com
Tue, 02/19/13 - 09:51 am
Amicus
Fabry's disease
Amigal
Orphan Drug Mania: Amicus / Migalastat HCl
Seeking Alpha
Thu, 02/7/13 - 10:10 am
Amicus
Migalastat HCl
orphan drugs
Fabry's disease
A Triple Play Of Biotech Disappointments Last Week
Investopedia
Fri, 12/28/12 - 11:45 am
Amicus
Hemispherx Biopharma
GSK
Oncothyreon
Amicus Fabry Drug Fails Pivotal Trial
TheStreet.com
Thu, 12/20/12 - 10:45 am
Amicus
Fabry's disease
Amigal
GSK
Amicus Soon To Release New Phase III Data
Seeking Alpha
Fri, 12/14/12 - 12:30 pm
Amicus
AT1001
Amigal
Migalastat HCl
Fabry's disease
Amicus: Bullish Options Trade Into Clinical Trial Catalysts
TheStreet.com
Tue, 12/4/12 - 01:36 pm
Amicus
clinical trials
Amigal
Several Biopharmas That Look Ready For Upside Gains
Yahoo/Reuters
Tue, 11/20/12 - 01:18 pm
Sarepta
BG Medicine
Amicus
Santarus
Celldex
Parkinson's Disease: 3 Different Firms, 3 Novel Approaches
Seeking Alpha
Thu, 08/16/12 - 01:47 pm
Parkinson's Disease
Amicus
Impax Laboratories
International Stem Cell Corp
Pages
1
2
next ›
last »